These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 9221520)
21. Axillary masses in a woman with a history of breast cancer: dermatopathic lymphadenopathy. Rocco N; Della Corte GA; Rispoli C; Sabatino V; Romano F; Altiero M; Sommella MG; Falco G; Compagna R; Amato B; Accurso A Int J Surg; 2014; 12 Suppl 2():S40-S43. PubMed ID: 25159542 [TBL] [Abstract][Full Text] [Related]
22. Breast imaging case of the day. Intramammary and axillary lymph node metastases from infiltrating lobular carcinoma of the breast. Cyrlak D; Carpenter PM Radiographics; 1999 Oct; 19 Spec No():S73-9. PubMed ID: 10517445 [No Abstract] [Full Text] [Related]
23. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680 [TBL] [Abstract][Full Text] [Related]
24. Abnormal axillary lymph nodes on negative mammograms: causes other than breast cancer. Görkem SB; O'Connell AM Diagn Interv Radiol; 2012; 18(5):473-9. PubMed ID: 22415745 [TBL] [Abstract][Full Text] [Related]
25. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? Specht MC; Fey JV; Borgen PI; Cody HS J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914 [TBL] [Abstract][Full Text] [Related]
26. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection. Tvedskov TF Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850 [TBL] [Abstract][Full Text] [Related]
27. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757 [TBL] [Abstract][Full Text] [Related]
28. Contribution of minute axillary lymph nodes to accurate staging for patients with breast cancer. Jiang J; He QQ; Yang XH; Liang Y; Fan LJ; Zhang Y; Guo MQ Chin Med J (Engl); 2007 Oct; 120(20):1762-5. PubMed ID: 18028767 [TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. Fornasa F; Nesoti MV; Bovo C; Bonavina MG J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570 [TBL] [Abstract][Full Text] [Related]
30. Axillary lymph nodes in breast cancer: is size related to metastatic involvement? Obwegeser R; Lorenz K; Hohlagschwandtner M; Czerwenka K; Schneider B; Kubista E World J Surg; 2000 May; 24(5):546-50. PubMed ID: 10787074 [TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
32. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology. Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548 [TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
34. Calcifications in metastatic breast carcinoma in axillary lymph nodes. Helvie MA; Rebner M; Sickles EA; Oberman HA AJR Am J Roentgenol; 1988 Nov; 151(5):921-2. PubMed ID: 2845762 [No Abstract] [Full Text] [Related]
35. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related]
36. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Mustonen P; Farin P; Kosunen O Ann Chir Gynaecol; 1990; 79(1):15-8. PubMed ID: 2192685 [TBL] [Abstract][Full Text] [Related]
37. The clinical importance of axillary lymphadenopathy detected on screening mammography. Murray ME; Given-Wilson RM Clin Radiol; 1997 Jun; 52(6):458-61. PubMed ID: 9202590 [TBL] [Abstract][Full Text] [Related]
38. Metastasis of primitive neuroectodermal tumor to the breast. Kwak JY; Kim EK; You JK; Oh KK; Hong SW; Kim SH J Clin Ultrasound; 2002; 30(6):374-7. PubMed ID: 12116099 [TBL] [Abstract][Full Text] [Related]
39. [Breast cancer: axillary dissection--or an unnecessary procedure?]. Schäfer P Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666 [TBL] [Abstract][Full Text] [Related]
40. New era in breast cancer. Impact of screening on disease presentation. Cady B Surg Oncol Clin N Am; 1997 Apr; 6(2):195-202. PubMed ID: 9103207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]